Bhaskar C. Behera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bhaskar C. Behera has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Sachin V. Mapari
Biodiversity – Lichens, Agharkar Research Institute, Pune, India
5 shared publications - Subhash B. Gaikwad
Biodiversity – Lichens, Agharkar Research Institute, Pune, India
5 shared publications - Roshni Khare
Biodiversity – Lichens, Agharkar Research Institute, Pune, India
4 shared publications - Ruchira R. Sutar
Biodiversity – Lichens, Agharkar Research Institute, Pune, India
4 shared publications - Muntjeeb Syed
Savitribai Phule Pune University Pune 411007 Maharashtra India
2 shared publications - Ravindra M. Patil
Genetics and Plant Breeding Group, Agharkar Research Institute, Pune, India
2 shared publications
Latest Publications
- 5 March 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (3)
From Symbiosis to Cytotoxicity: Biosynthesis, Molecular Mechanisms, and Anticancer Potential of Lichen‐Derived Depsides and Depsidones
Lichen is a unique symbiotic organism that consists of fungi and photosynthetic algae and or cyanobacteria. They are known for producing a large repository of secondary metabolites, among which depsides and depsidones gain pharmacological interest. This review meticulously examines the anticancer efficacy of lichen‐derived depsides and depsidones, with a focus on their chemical composition, biosynthetic pathways, and molecular mechanisms that underpin their antitumor activities across various cancer cell lines. These compounds have shown notable bioactivities, including cytotoxicity, apoptosis, and suppression of critical oncogenic cascades such as cellular proliferation, metastasis, and angiogenesis. In some studies, they have shown their selectivity for malignant cells while having minimal cytotoxicity towards healthy cells. This review also addresses the challenges for isolation and large‐scale production of these metabolites and also explores the aspect of chemical synthesis or designing of synthetic analogues to increase stability, potency, and pharmacokinetic profile. In conclusion, this review emphasizes the potential application of depsides and depsidones as natural anticancer drugs, as studies strongly recommend conducting further analysis using laboratory models.
- 5 March 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (3)
From Symbiosis to Cytotoxicity: Biosynthesis, Molecular Mechanisms, and Anticancer Potential of Lichen‐Derived Depsides and Depsidones
Lichen is a unique symbiotic organism that consists of fungi and photosynthetic algae and or cyanobacteria. They are known for producing a large repository of secondary metabolites, among which depsides and depsidones gain pharmacological interest. This review meticulously examines the anticancer efficacy of lichen‐derived depsides and depsidones, with a focus on their chemical composition, biosynthetic pathways, and molecular mechanisms that underpin their antitumor activities across various cancer cell lines. These compounds have shown notable bioactivities, including cytotoxicity, apoptosis, and suppression of critical oncogenic cascades such as cellular proliferation, metastasis, and angiogenesis. In some studies, they have shown their selectivity for malignant cells while having minimal cytotoxicity towards healthy cells. This review also addresses the challenges for isolation and large‐scale production of these metabolites and also explores the aspect of chemical synthesis or designing of synthetic analogues to increase stability, potency, and pharmacokinetic profile. In conclusion, this review emphasizes the potential application of depsides and depsidones as natural anticancer drugs, as studies strongly recommend conducting further analysis using laboratory models.
- 15 November 2023
- Published by Wiley in Chemistry & Biodiversity
- Vol. 20 (12) , e202301229
In Vitro and in Silico Studies of Lichen Compounds Atranorin and Salazinic Acid as Potential Antioxidant, Antibacterial and Anticancer Agents
Lichens are symbiotic organisms made up of alga/cyanobacterium and fungus. We investigated antioxidant, antibacterial and anticancer properties of two lichen compounds, atranorin and salazinic acid, and five lichen species: Heterodermia boryi, Heterodermia diademata, Heterodermia hypocaesia, Parmotrema reticulatum, and Stereocaulon foliolosum. Free radical scavenging, Ferric reducing potential, Nitric oxide scavenging, and Trolox equivalent capacity were used to measure antioxidant activity. Strong radical scavenging action was demonstrated by atranorin and salazinic acid, with IC50 values of 39.31 μM and 12.14 μM, respectively. The Minimum Inhibitory Concentration (MIC) assay based on resazurin, was used to measure antibacterial activity. Parmotrema reticulatum demonstrated significant antibacterial activity against Raoultella planticola with MIC of 7.8 μg/mL. Cytotoxicity assay on breast cancer cell line was used to assess anticancer activity. To further understand the binding locations on the target proteins Er (Estrogen Receptor alpha), EGFR (Epidermal Growth Factor Receptor), mTOR (Mammalian Target of Rapamycin), and PgR (Progesterone Receptor), molecular docking experiments were conducted. Docking study showed that the binding energies of atranorin and salazinic acid with mTOR were −5.31 kcal/mol and −3.43 kcal/mol, respectively. The results suggest that atranorin has the potential to be a multitargeted molecule with natural antioxidant, antibacterial, and anticancer properties.
- 15 November 2023
- Published by Wiley in Chemistry & Biodiversity
- Vol. 20 (12) , e202301229
In Vitro and in Silico Studies of Lichen Compounds Atranorin and Salazinic Acid as Potential Antioxidant, Antibacterial and Anticancer Agents
Lichens are symbiotic organisms made up of alga/cyanobacterium and fungus. We investigated antioxidant, antibacterial and anticancer properties of two lichen compounds, atranorin and salazinic acid, and five lichen species: Heterodermia boryi, Heterodermia diademata, Heterodermia hypocaesia, Parmotrema reticulatum, and Stereocaulon foliolosum. Free radical scavenging, Ferric reducing potential, Nitric oxide scavenging, and Trolox equivalent capacity were used to measure antioxidant activity. Strong radical scavenging action was demonstrated by atranorin and salazinic acid, with IC50 values of 39.31 μM and 12.14 μM, respectively. The Minimum Inhibitory Concentration (MIC) assay based on resazurin, was used to measure antibacterial activity. Parmotrema reticulatum demonstrated significant antibacterial activity against Raoultella planticola with MIC of 7.8 μg/mL. Cytotoxicity assay on breast cancer cell line was used to assess anticancer activity. To further understand the binding locations on the target proteins Er (Estrogen Receptor alpha), EGFR (Epidermal Growth Factor Receptor), mTOR (Mammalian Target of Rapamycin), and PgR (Progesterone Receptor), molecular docking experiments were conducted. Docking study showed that the binding energies of atranorin and salazinic acid with mTOR were −5.31 kcal/mol and −3.43 kcal/mol, respectively. The results suggest that atranorin has the potential to be a multitargeted molecule with natural antioxidant, antibacterial, and anticancer properties.
- Open Access
- 24 February 2021
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 20, 491-494
Neuroprotective potential of selected lichen compounds on mouse neuroblastoma (N2a) cells
- 24 February 2021
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 20, 491-494
Open AccessNeuroprotective potential of selected lichen compounds on mouse neuroblastoma (N2a) cells